Examining HIV Diagnosis and Linkage to PrEP Prescription Among Members at An Integrated Health System in the Southeast United States-Reference-Cited by-同舟云学术

Examining HIV Diagnosis and Linkage to PrEP Prescription Among Members at An Integrated Health System in the Southeast United States

Published:2022-09-12 Issue:3 Volume:27 Page:796-805
ISSN:1090-7165
Container-title:AIDS and Behavior
language:en
Short-container-title:AIDS Behav

Author:

Davis Teaniese L.,Mittal Mona,Oragwu Adanna C.,Wang Min Qi,Boekeloo Bradley O.^ORCID

Funder

National Center for Chronic Disease Prevention and Health Promotion

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology

Link

https://link.springer.com/content/pdf/10.1007/s10461-022-03812-4.pdf

Reference54 articles.

1. CDC. Pre-Exposure P, Atlanta. GA: U.S. Department of Health & Human Services; 2018 [Available at: https://www.cdc.gov/hiv/risk/prep/index.html .] Accessed August 4, 2022.

2. Tanner MR, Miele P, Carter W, et al. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020. MMWR Recomm Rep 2020;69(No. RR-3):1–12. DOI: https://doi.org/10.15585/mmwr.rr6903a1.

3. FDA approves second drug to. prevent HIV infection as part of ongoing efforts to end the HIV epidemic [press release]. Food and Drug Administration, 2019.[Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-second-drug-prevent-hiv-infection-part-ongoing-efforts-end-hiv-epidemic.] Access August 4, 2022.

4. CDC. PrEP Effectiveness. [Available at: https://www.cdc.gov/hiv/basics/prep/prep-effectiveness.html .] Accessed on August 4, 2022.

5. Surveillance CDCHIV, Report. 2018 (Updated). MMWR. 2020;Vol.31. [Available at: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2018-updated-vol-31.pdf .] Accessed on August 4, 2022.